Akari therapeutics plc

Major-Pharmaceuticals

AKTX


24 West 40th Street
New York , NY 10018

Executive/
Director

Price

  • Last Close
  • $ 0.19
    $ -0 -0.53 %
    Aug 16, 2023
  • 52-Week High/Low
  • $0 - $0
  • YTD
  • 0%

  • Trading Volume
  • 233,823
  • Market Cap Full
  • $ 1.4B
  • Shares Outstanding
  • 7444.9M
    Dec 31, 2022
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 -3.5% 57.2% -58% 128% -5% 42.7% -19.5% -62.9% - -
Q2 -3.6% -58.4% 6% -43.4% 4% -34.5% -16.7% -6.6% - -
Q3 -36.9% 33.2% 22.5% -16.6% 8% -5.8% -37% 10.6% - -
Q4 -17.3% -32.7% -37% 0.6% 6.3% -8.6% -22.2% - - -
J F M A M J J A S O N D
2025 - - - - - - - - - - - -
2024 - - - - - - - - - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%-51%-38%-64%10%8%-19%-67%-62%0%0%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 - 0.09 - - - -0.15 -0.1 -
Q2 0.45 0.06 -1 - -0.28 -0.11 -0.1 -
Q3 0.03 0.09 - - - -0.03 - -
Q4 0.08 0.07 - -0.74 -0.72 0.29 - -
A 0.6 0.3 -1 -0 -0 -5.5511151231258E-17 -0.2 0

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022
Mar - - - - -
Jun 1525.7 - - - -
Sep - - - - -
Dec 1580.7 2245.9 3847.3 4759.7 7444.9
Annual

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 4.6 - 18 - 5
Equity multiplier - - - - 0.3